NON-SMALL CELL LUNG CANCER

This adverse event was reported 2919 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER:

# Drug Count
0 CARBOPLATIN 365
1 CRIZOTINIB 266
2 PACLITAXEL 243
3 ERLOTINIB HYDROCHLORIDE 198
4 BRIGATINIB 195
5 PEMETREXED DISODIUM 180
6 PEMETREXED 141
7 BEVACIZUMAB 122
8 CERITINIB 122
9 DEXAMETHASONE 122
See all common drugs associated with NON-SMALL CELL LUNG CANCER

NON-SMALL CELL LUNG CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MOBOCERTINIB 26 0.1040
1 BRIGATINIB 195 0.1007
2 SOTORASIB 58 0.0864
3 CERITINIB 122 0.0564
4 CAPMATINIB 61 0.0443
5 DEMECLOCYCLINE 5 0.0253
6 CRIZOTINIB 266 0.0249
7 BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE 1 0.0127
8 CHLOROXYLENOL 1 0.0122
9 BENZETHONIUM CHLORIDE 1 0.0105
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER